VIRAL
IMMUNOLOGY
VOLUME 12 NUMBER 1 1999
Recombinant Fusion Protein and DNA Vaccines Against Foot and Mouth Disease Virus Infection in Guinea Pig and Swine H. Huang, Z. Yang, Q. Xu, Z. Sheng, Y. Xie, W. Yan, Y. You, L. Sun, and Z. Zheng 1
Antigen-Specific In Vitro Activation of T-Lymphocyte Subsets of Cattle Immunized with a Modified Live Bovine Herpesvirus I Vaccine M.J. Quade and J.A. Roth 9
Enhanced Human Immunodeficiency Virus Infection in Macrophages by High-Molecular-Weight Dextran Sulfate Is Associated with Conformational Changes of gpl20 and Expression of the CCR5 Receptor P.P. Jagodzinski, A. Wierzbicki, J. Wustner, Y. Kaneko, and D. Kozbor 23
Delayed Administration of lnterleukin-12 Is Efficacious in Promoting Recovery from Lethal Viral Encephalitis D.D.C. Ireland, T. Bang, T. Komatsu, and C.S. Reiss 35
A Novel and Effective Intranasal Immunization Strategy for Respiratory Syncytial Virus P.W. Tebbey, C.A. Unczur, N.A. LaPierre, and G.E. Hancock 41
Simian Retrovirus Receptor and Neutralization Mechanism by Antibodies to the Envelope Glycoprotein D. E. Anderson and J.V. Torres 47
Epitope Mapping of Rat Neutralizing Monoclonal Antibody Against Human Immunodeficiency Virus Type-1 by a Phage Peptide Library: Comparison with ELISA Using Synthetic Peptides
K. Ichiyama, D. Ishikawa, Y. Tanaka, T. Kashiwa, Y. Koyanagi, S. Handa, A. Yamashita, M. Fukushi, N. Yamamoto, and T. Taki 57
Immunization of Neonates with DNA Encoding a Bovine Herpesvirus Glycoprotein Is Effective in the Presence of Maternal Antibodies S. van Drunen Littel-van den Hurk, R.P. Braun, P.J. Lewis, B.C. Karvonen, L.A. Babiuk, and P.J. Griebel 67
Characterization of Neutralizing Sites in the Second Variable and Fourth Variable Region in gpl25 and a Conserved Region in gp36 of Human Immunodeficiency Virus Type 2 P. Skott, A. Achour, M. Norin, R. Thorstensson, and E. Bjorling 79
Erratum 89 Instructions to Authors can be found at the back of the issue.
___________________________________________
VIRAL IMMUNOLOGY
VOLUME 12 , NUMBER 2 , 1999
Induction of Antibody Response by DNA Immunization of Newborn Baboons 91
Against Influenza Virus
A. Bot, M. Shearer, S. Bot, C. Woods, J. Limmer, R. Kennedy, S. Casares, and C. Bona
Recombinant Vaccinia Viruses Protect Against Clostridium perfringens 97
a-Toxin
A.M. Bennett, T. Lescott, R.J. Phillpotts, M. Mackett, and R.W. Titball
Antigen-Specific Cytokine and Antibody Isotype Profiles Induced by Mucosal 107
and Systemic Immunization with Recombinant Adenoviruses
Z. Papp, L.A. Babiuk, and M.E. Baca-Estrada
Induction of Cytotoxic and Helper T Cell Responses by Modified Simian 117
Immunodeficiency Virus Hypervariable Epitope Constructs
D. Meyer and J. V. Torres
Relationship Between Immunoclinical Status and Prevalence of Viral Sexually 131
Transmitted Diseases Among Human Immunodeficiency Virus-1 Seropositive
Patients in Ghana
J .A.M. Brandful, F.A. Apeagyei, W.K. Ampofo, Y. Adu-Sarkodie, J.E. Ansah, V. Nuvor,
S. Aidoo, K. Ishikawa, T. Sata, N. Yamamolo, and S. Yamazaki
Correlation of Clinical Parameters and Immunological Function with Human 139
Immunodeficiency Virus Plasma Viremia in Children
V. B. Peters, L. Mayer, and K.E. Sperber
Bovine Lymphocyte Antigen-All-Specific Peptide Motif as a Means to 149
Identify Cytotoxic T-Lymphocyte Epitopes of Bovine Herpesvirus I
N.R. Hegde, M.S. Deshpande, D.L. Godson, L.A. Babiuk, and S. Srikumaran
Regulation of Immune Complexes During Infection of Mice with Lactate 163
Dehydrogenase-Elevating Virus: Studies with Interferon-y Gene Knockout
and Tolerant Mice
W.A. Cafruny, S.E. Bradley, and R.R.R. Rowland
___________________________________________